DeegH.F.. Ultraviolet irradiation in transplantation biology: manipulation of immunity and immunogenicity.Transplantation1988; 45: 845.
8.
DeggH.F.. Modification of allointerations after blood transfusion and marrow transplantation by ultraviolet light.Semin Hematol1992; 29: 95.
9.
DeegH.F., EricksonK., StorbR., SullivanK.M.. Photoinactivation of lymphopoietic cells: studies in transfusion medicine and bone marrow transplantation.Blood Cells1992; 18: 151.
10.
GuptaA.K., AndersonT.F.. Psoralen photochemotherapy.J Am Acad Dermatol1987; 17: 703.
EppingerT., EhningerG., SteinertM., NietbammerD., DopferR.: 8-methoxypsoralen and ultraviolet. A therapy for cutaneous manifestations of graft-versus-host disease.Transplantation1990; 50: 807.
KapoorN., PelligriniA.E., CopelanE.A.. Psoralen plus ultraviolet A (PUVA) in the treatment of chronic graft versus host disease: preliminary experience in standard treatment resistant patients.Semin Hematol1992; 29: 108.
AubinF., BrianA., DeconinckE.. Phototherapy in the treatment of cutaneous graft-versus-host disease: our preliminary experience in resistant patients.Transplantation1995; 59: 151.
18.
VogelsangG.B., WolffD., AltomonteV.. Treatment of chroic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA).Bone Marrow Transplant1996; 17: 1061.
19.
EdelsonR.L., BergerC., GasparroF.. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: preliminary results.New Engl J Med1987; 316: 297.
20.
RookA.H., FreundlichB., FegasothyB.V.. Treatment of systemic sclerosis with extracorporeal photochemotherapy: results of a multicenter trial.Arch Dermatol1991; 128: 337.
21.
RookA.H.. Photopheresis in the treatment of autoimmune disease: experience with pemphigus vulgaris and systemic sclerosis.Ann NY Acad Sci1991; 636: 209.
22.
Dall'AmicoR., ZacchelloG., HealdP.. The application of photopheresis in the therapy of cancerous and autoimmune diseases.Recenti Prog Med1991; 82: 294.
23.
MalawistaS.E., TrockD.H., EdelsonR.L.. Treatment of rheumatoid arthritis by extracorporeal photochemotherapy. A pilot study.Arthritis Rheum1991; 34: 646.
Costanzo-NordinM.R., HubbellB.A., O'SullivanE.F.. Successful treatment of heart transplant rejection with photopheresis.Transplantation1992; 53: 808.
26.
RoseB.A., BarrM.L., XuH.. Photochemotherapy in human heart transplant recipients at high risk for fatal rejection.J Heart Lung Transplant1992; 11: 746.
27.
HeshmatiF., AchkarA., GuillemainR., CouetilF.P., AndreuG.. Lung transplant rejection successfully treated by extracorporeal photochemotherapy: a case report (abstract).J Clin Apheresis1994; 9: 51.
HorinaF., MullegerR., HornS.. Photopheresis for renal allograft rejection.Lancet1995; 346: 61.
30.
MeiserB.M., KurF., ReichenspurnerH.. Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation.Transplantation1994; 57: 563.
31.
BarrM., MeiserB., BisenH.. Photopheresis for the prevention of rejection in cardiac transplantation.N Engl J Med1998; 339; 24: 1744–50.
32.
BolwellB., FishlederA., LichtinA.. Photopheresis in the treatment of chronic graft vs. Host disease (cGVHD) (Abstract).Blood1990; 76(Suppl 1): 529a.
33.
SniecinskiI., SmithB., ParkerP.M.. Extracorporeal Photochemotherapy for treatment of drug resistant graft versus host disease (abstract).J Clin Apheresis,1995; 10: 51.
Dall'AmicoR., RossettiF., ZulianF.. Photopheresis in pediatric patients with drug-resistant chronic graft-vs-host disease.Br J Haematol1997; 97: 848–54.
36.
AbhyankarS., BishopM.. Adjunctive treatment of resistant chronic graft-versus-host disease, with extracorporeal photopheresis, using UVADBX Sterile Solution.J Am Soc Hematol1998; 92: 454 (abstract 1876).
37.
SniecinskiI., ParkerP., DagisA.. Extracorporeal photopheresis (EP) is effective treatment for chronic refractory graft-versus host disease.J Am Soc Hematol1998; 92: 454 (abstract 1877).
38.
GreinixH., Volc-PlatzerB., RabitschW.. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease.Blood1998; 92: 3098–104.
39.
ChildF.J., RatnavelR., WatkinsP.. Extracorporeal photopheresis (BCP) in the treatment of chronic graft-versus-host disease (GVHD), Bone Marrow Transplantation1999; 23: 881–7.
40.
ZicJ., MillerJ., StricklinG., KingL.Jr.. The North American experience with photopheresis.Therapeutic Apheresis1999; 3: 51 (abstract).
41.
SalvaneschiL., PerottiC., ViarengoG.. Personal Communication.
42.
GreinixH.T., Volc-PlatzerB., KalhsP.. Excellent remission of acute graft-versus-host disease after extracorporeal photochemotherapy (ECP).Bone Marrow Transplantation1999; 23: 1 (abstract).
43.
BloomE.J., TelangG.H., JegasothyB.V.. Extracorporeal chemophotopheresis (ECPP) in treatment of chronic graft versus host disease (C-GVHD) after allogeneic bone marrow transplantation (Al lo BMT). American Society of Clinical Oncology: Annual Meeting, May 19–21, 1991.
44.
OwsianowskiM., GollnickH., SiegertW., SchwerdtfegerR., OrfanosB.E.. Successful treatment of chronic graft-versus-host disease with extracorporeal phtopheresis.Bone Marrow Transplantation.1994; 14: 845–8.
45.
RossettiF., ZulianF., Dall'AmicoR., MessinaC., MontiniG., ZacchelloF.. Extracorporeal photochemotherapy as single therapy for extensive cutaneous, chronic graft-versus-host disease.Transplantation1995; 59: 149–51.
46.
BaldaB-R, KonstantinowA., StarzH., GnekowA., HeidemannP.. Extracorporeal photochemotherapy as an effective treatment modality in chronic graft-versus-host disease.J Eur Acad Dermatol Venereol1996; 7: 155–62.
47.
KonstantinowA., BaldaB-R, StarzH., GnekowA., HeidemaunP.. Chronic graft-versus host disease: successful treatment with extracorporeal photochemotherapy: a follow-up.Br J Dermatol1996; 135: 1007–8.
48.
RossettiF., Dall'AmicoR., CrovettiG.. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplantation - Proceedings of the 2nd International Course on Bone Marrow Transplantation in Children, Brice, Italy, 27–30 April 1996 (supp. 2): 175–80.
49.
SchoonemanF., ClaiseC.. Treatment of graft-vs-host disease (GVHD) by photopheresis?Transfusion Science1996; 17: 527–36.
50.
RichterH., StegeH., RuzickaT., SoehngenD., HeyllA., KrutmannJ.. Extracorporeal photopheresis in the treatment of acute graft-vs-host disease.J Am Acad Dermatol1997; 36: 787–9.
51.
LooksA., FuchsD., RulkeD., LangeD., ZintiF., WollinaU.. Successful treatment of acute graft-versus-host disease after allogenieic bone marrow transplantation in a 16-year-old girl with extracorporeal photopheresis.Onkologie1997; 340–2.
52.
GerberM., GmeinhartB., Volc-PlatzerB., KalhsP., GreinixR., KnoblerR.. A Complete remission of lichen-planus-like graft-versus-host disease (GvHD) with extracorporeal photochemotherapy (ECP).Bone Marrow Transplantation1997; 19: 517.
53.
Russell-JonesR.. Extracorporeal photopheresis in chronic cutaneous graft-versus-host disease.Editorial - Bone Marrow Transplantation1998; 22: 621–3.
54.
PerottiC., TorrettaL., ViarengoG.. Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures.Haematologica1991; 84: 237–41.
55.
YooE., RookA., ElenitsasR., GasparroF., VowelsB.. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action.J Invest Dermatol1996; 107: 235–42.
56.
MiraccoC., RubegniP., De AloeG.. Extracorporeal photochemotherapy induces apoptosis of infiltrating lymphoid cells in patients with mycosis fungoides in early stages. A quantitative histological study.Br J Dermatol1997; 137: 549–57.
57.
VowelsB.R., CassinM., BoufalM.H., WalshU., RookA.H.. Extracorporeal photochemotherapy induces the production of tumor necrosis factor by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosisJ Invest Dermatol1992; 98: 686–92.
58.
Di RenzoM., RubegniP., De AloeG.. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma.Immunology1997; 92: 99–103.
59.
VonderheidB.C., TanB., SobelE.L.. Clinical implications of immunologic phenotyping in cutaneous T cell lymphoma.J Am Acad Dermatol1987; 17: 40–52.
60.
CharleyM.R., DengJ-S. Murine models of graft-versus-host disease with features of scleroderma. In: NorrisD., ed. Immune mechanisms in cutaneous disease.New York: Marcel Dekker, 1989: 25–40.
61.
ArlettC.M., SmithJ.B., JimenezS.A.. Indentification of fetal DNA and cells in skin lesions from women with systemic sclerosis.N Engl J Med1998; 338: 1186–91.
62.
KnoblerR.M., TrautingerF., Graninger. Parenteral administration of 8-methozypsoralen in photopheresis.J Am Acad Dermatol1993; 28: 580–4.
63.
SniecinskiI.. Frequency of adverse events related to extracorporeal photochemotherapy procedures.J Clin Apheresis1998; 13: 82.
64.
SmithE., SniecinskiI., DagisA.. Extracorporeal photochemotherapy for treatment of drug-resistant graft-versus-host disease.Biology of Blood and Marrow Transplantation1998; 4: 27–37.